Clinical Trial Update: Phase 3 Study of EBI-005 in Dry Eye Disease [Phase 3]

View source ↗

Summary

Phase 3 trial of EBI-005 for dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• EBI-005

Snippet

Sponsor: Eleven Biotherapeutics | Conditions: Dry Eye Disease (DED) | Phase 3 | Status: COMPLETED